A paralyzed man is walking again thanks to a pioneering stem cell therapy developed by Japanese scientists. The procedure, conducted at Keio University in Tokyo, represents a major milestone in regenerative medicine and spinal cord injury treatment, with researchers calling it the first time reprogrammed stem cells have successfully improved motor function in human patients with severe paralysis.
The Science Behind the Recovery
The treatment uses induced pluripotent stem cells (iPSCs), which are adult cells—typically from skin or blood—that scientists genetically reprogram to behave like embryonic stem cells. These cells have the remarkable ability to transform into nearly any cell type, including neurons, making them a powerful tool for repairing damaged tissue.
The reprogramming process relies on what are known as Yamanaka factors, four specific genes identified by Nobel Prize-winning scientist Shinya Yamanaka. When inserted into mature cells using methods like mRNA or viral vectors, the factors revert these cells back to a pluripotent state. Once reprogrammed, the cells can be directed to become neural stem cells capable of rebuilding damaged nerve networks.
Dr. Hideyuki Okano, the lead researcher at Keio University, had already demonstrated the effectiveness of these cells in animals. In prior studies, his team was able to regenerate spinal cord tissue in monkeys. After receiving government approval in 2019, they moved to human trials.
The Human Trial: From Paralysis to Standing
Between 2021 and 2023, Dr. Okano’s team conducted surgeries on four Japanese men, all of whom had suffered recent and complete spinal cord injuries. Each patient received an injection of two million iPSCs directly into the damaged area of the spinal cord within four weeks of injury. All four were also given immune-suppressing drugs for six months to prevent rejection.
After one year, two patients showed marked improvements. One elderly man regained the ability to stand with support and is now undergoing rehabilitation to learn how to walk again. His motor function score jumped from the lowest level, A, to D on a scale of A to E. Another patient improved to a level C and can now feed himself—something he was unable to do before the treatment.
The remaining two participants did not experience significant recovery. However, Dr. Okano emphasized that the study was primarily designed to assess safety, not efficacy. Importantly, none of the patients experienced serious side effects, a key indicator that the therapy is safe for further trials.
A Glimpse of Hope for Millions
Worldwide, more than 15 million people live with spinal cord injuries, and effective treatments have long been out of reach. According to The Japan Times, over 150,000 people in Japan alone are paralyzed from such injuries, with 5,000 new cases each year.
“There is currently no effective treatment for paralysis caused by serious spinal cord injuries,” Okano told reporters. “This is a dramatic recovery. That person is now training to walk.”
James St. John, a neuroscientist from Griffith University in Australia, echoed the optimism but urged caution. “That’s a great positive outcome. It’s very exciting for the field,” he said. But he also noted that further studies with more patients and control groups are needed. “Nothing’s really worked so far,” he added, referring to previous failed efforts using bone marrow cells or fetal-derived stem cells.
Next Steps for the Therapy
Following the promising results, Dr. Okano’s team plans to launch larger clinical trials to secure regulatory approval and refine the treatment. Scientists also hope to better understand which patients are most likely to benefit and how to optimize timing and dosage.
The study opens new doors not only for spinal injury patients but also for other regenerative therapies. Research is already underway to use partial cellular reprogramming to reverse aging in cells and restore function in other organs.
Prevention Still Matters
While stem cell therapy may one day reverse paralysis, preventing spinal injuries remains essential—especially among older adults. Falls are the leading cause of such injuries in those over 65, according to the Mayo Clinic. A large analysis of more than 23,000 people found that exercise routines focusing on balance, core strength, and resistance training can reduce fall risk by 23 percent.
Maintaining strength and balance could reduce the likelihood of life-altering injuries in aging populations. Until stem cell therapy becomes widely available, prevention remains the best strategy.
A New Chapter in Medicine
Though still in its early stages, this breakthrough stem cell therapy gives new hope to patients once told their conditions were permanent. As trials expand and techniques improve, the dream of helping paralyzed individuals walk again may become a reality for more people around the world.
